Evosep

Evosep, founded in 2016 by proteomics pioneer Ole Vorm and led by CEO Christian Ravnsborg, aims to improve quality of life and patient care by unlocking the potential of LC-MS for drug discovery and innovating how protein-based clinical diagnostics are performed on panels with multiple protein biomarkers. Its platform offers high sample throughput capability with reproducibility between sample runs as well as across instruments and sites (i.e., valuable, actionable data). The technology shapes the potential of proteomics by developing valuable applications, enabling broad adoption, and advancing protein-based diagnostics with clinical significance.